Covigilant Research, LLC

Committed To Working Together

Coronavirus by the Numbers: COVID-19 Metrics by Region in Illinois

December 21, 2020 December 21, 2020

Several Illinois healthcare regions are within parameters to move forward from Tier 3 coronavirus mitigations, while others are seeing numbers slowly …Read More

RegeneRx Comments on ARISE-3 Clinical Trial - Jan 26, 2021
on January 26, 2021
"Based on current communication with GtreeBNT, our partner in the 700-patient ARISE-3 clinical trial, the patient database is continuing to be cleaned ...
Regeneron Monoclonal Antibody Study | Office of Academic Clinical Affairs - University of Minnesota
on January 26, 2021
Has someone in your household recently been diagnosed with COVID-19? Volunteer for a Clinical Trial. The University of Minnesota Medical School ...
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
on January 26, 2021
The companies are collaborating to rapidly develop, deploy, and manage clinical research sites across the country using Care Access' Mobile Sites On ...
RegeneRx Comments on ARISE-3 Clinical Trial
on January 26, 2021
RGN-259, the Company's ophthalmic eye drop, recently complete a phase 3 clinical trial for dry eye syndrome in the U.S. and is expected to report top ...
CNS-focused Karuna snags BMS vet to spearhead clinical pipeline
on January 26, 2021
Blazing a Trail to Clinical Trial Diversity: Four-Part Webinar Series from Syneos Health, Featuring Pharma, Clinical Research and Community Health ...
Canadian-made COVID-19 vaccine to begin human clinical trials
on January 26, 2021
Toronto-based Providence Therapeutics announced it has begun dosing the volunteers in human clinical trials of its COVID-19 vaccine. The vaccine ...
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once ...
on January 26, 2021
“These results provide support for further study of islatravir as a once-monthly oral PrEP regimen,” said Sharon Hillier, Ph.D., senior investigator at the ...
PharmaCyte Biotech Begins DNA Sequence and Stability Studies in Response to FDA Requests ...
on January 26, 2021
PharmaCyte Biotech Begins DNA Sequence and Stability Studies in Response to FDA Requests for its Clinical Trial Product. Published: Jan 26, 2021.
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once ...
on January 26, 2021
Islatravir (formerly MK-8591) is Merck's investigational nucleoside reverse transcriptase translocation inhibitor (NRTTI) under evaluation in clinical trials ...
HCA Healthcare Uses Its COVID-19 Registry by Forming Consortium With AHRQ and Research ...
on January 26, 2021
A leader in drug development, Sarah Cannon has led more than 450 first-in-human oncology clinical trials since its inception in 1993 and has been a ...
Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 ...
on January 26, 2021
The Care Access and AstraZeneca teams are collaborating to rapidly develop, deploy, and manage clinical research sites across the country, using ...
Calgary company begins human clinical trials for its COVID-19 vaccine candidate
on January 26, 2021
CALGARY — Human clinical trials have begun in Toronto for a proposed COVID-19 vaccine made by a Canadian company. Providence Therapeutics ...

S	M	T	W	T	F	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31